Hydroxychloroquine and Coronavirus

Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro.

/

Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro.

Straight from Wuhan, China, the lab that discovered COVID-19. And wouldn’t these doctors know best?

Doctors Jia Liu, Ruiyuan Cao, Mingyue Xu, Xi Wang, Huanyu Zhang, Hengrui Hu, Yufeng Li and Zhihong Hu, Wu Zhong and Manli Wang.

As they wrote:

“Dear Editor,
The outbreak of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2/2019-nCoV) poses a serious threat to global public health and local economies. As of March 3, 2020, over 80,000 cases have been confirmed in China, including 2946 deaths as well as over 10,566 confirmed cases in 72 other countries. Such huge numbers of infected and dead people call for an urgent demand of effective, available, and affordable drugs to control and diminish the epidemic.
We have recently reported that two drugs, remdesivir (GS-5734) and chloroquine (CQ) phosphate, efficiently inhibited SARS-CoV-2 infection in vitro.”

Read the full article – Hydroxychloroquine a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro

And wouldn’t they know best?

Leave a Reply

Your email address will not be published.

Hydroxochloriquine and COVID-19
Previous Story

Twice as Many Lived...

Clinical Trials NIH Coronavirus Vaccine
Next Story

Now the mind game begins...The actual study in using the best tactics to appeal to your emotions to take the vaccine.

Latest from COVID-19